| Issue 1120: May 13, 2014 TOP STORIES
IAC HANDOUTS FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS
EDUCATION AND TRAINING TOP STORIES CDC's Health Alert Network publishes an advisory to alert clinicians about a case of Middle East Respiratory Syndrome Coronavirus in Indiana On May 2, the first confirmed case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was reported in a traveler to the United States. On May 3, the CDC Health Alert Network (HAN) issued a CDC Health Advisory titled Confirmed Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Case in Indiana, 2014. This advisory is intended to alert clinicians, health officials, and others to increase their index of suspicion to consider MERS-CoV infection in travelers from the Arabian Peninsula and neighboring countries. The "Summary" section is reprinted below. Other advisory sections that you may wish to consult are titled "Background," "Recommendations," and “For More Information.” The first case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in the United States, identified in a traveler, was reported to CDC by the Indiana State Department of Health (ISDH) on May 1, 2014, and confirmed by CDC on May 2. The patient is in a hospital in Indiana after having flown from Saudi Arabia to Chicago via London. The purpose of this HAN is to alert clinicians, health officials, and others to increase their index of suspicion to consider MERS-CoV infection in travelers from the Arabian Peninsula and neighboring countries. Please disseminate this information to infectious disease specialists, intensive care physicians, primary care physicians, and infection preventionists, as well as to emergency departments and microbiology laboratories. Related Links
CDC study shows LAIV being administered to people for whom it is not recommended On May 8, the Journal of the Pediatric Infectious Diseases Society published a paper titled “Post-licensure Surveillance of Trivalent Live Attenuated Influenza Vaccine in Children Aged 2–18 Years, Vaccine Adverse Event Reporting System (VAERS), United States, July 2005–June 2012.” A related CDC bulletin concluded: The study, which assessed the safety of trivalent live attenuated influenza vaccine (LAIV3) in children in the Vaccine Adverse Events Reporting System (VAERS) during 2005–2012, did not find any new or unexpected adverse event patterns. However, it did find that LAIV3 was still being given to persons for whom the vaccine is not recommended (e.g., persons with a history of asthma or reactive airway disease/wheezing), suggesting that ongoing monitoring and education in this area is needed. Related Links
IAC Spotlight! Ten more healthcare organizations join IAC's Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination IAC urges qualifying healthcare organizations to apply for its Influenza Vaccination Honor Roll. The honor roll recognizes hospitals, medical practices, professional organizations, health departments, and government entities that have taken a stand for patient safety by implementing mandatory influenza vaccination policies for healthcare personnel. More than 400 organizations are now enrolled. Since April 15, when IAC Express last reported on the Influenza Vaccination Honor Roll, ten organizations have been enrolled. Newly added healthcare organizations, medical practices, and health agencies
IAC adds new resources to its Adult Vaccination Resource Library In 2013, the Immunization Action Coalition, in collaboration with the National Adult and Influenza Immunization Summit, developed the Adult Vaccination Resources Library (AVRL). This online library gives healthcare providers and the general public one-stop access to reliable, science-based information about adult immunization. IAC recently added new content for a total of 250 adult immunization resources from a multitude of publishers. The library allows providers and the public to use simple keywords and other selection criteria—such as vaccine, special population, and language—to pinpoint pertinent resources that can be used in a clinic setting or for individual education. Resources are available in many media: print, video, online, web-on-demand, interactive, and others. To speed your search, please read tips on how to search the library. We invite you to try out the new library and provide feedback. To offer comments, report broken links, or submit suggestions for resources that should be included, please send an email to Laurel Wood and include “AVRL Suggestion” in the email subject line. Back to top Let CDC know how you celebrated National Infant Immunization Week Now that National Infant Immunization Week (NIIW) has come to a close, CDC is eager to hear about your efforts to protect infants from vaccine-preventable diseases. If your organization held an NIIW 2014 activity, please let CDC know by filling out the online NIIW Activity Form. The NIIW web section includes many useful resources that can be used year-round. Back to top Join the Voices for Vaccines' May 16 conference call featuring Karrie Delaney and introducing VFV's Parent Advocacy Toolkit Voices for Vaccines (VFV) aims to motivate and inspire parents to speak up on behalf of immunizing children, while making it easy to do so. On May 16, at 12:00 p.m. (ET), VFV will sponsor a conference call that will show parents how easy it is to speak up for immunization. The call will feature Karrie Delaney, a communication strategist committed to charitable work, who will tell her story of advocating for vaccines and introduce VFV's Parent Advocate Toolkit. To register for this call, you must email info@voicesforvaccines.org. Voices for Vaccines is a national organization of parents and others who are dedicated to raising the level of the voices of immunization supporters. VFV invites everyone who appreciates vaccines to become a member of their organization. Please spread the word to your friends and colleagues to register for the conference call and to join VFV! Back to top Final reminder: National Conference on Immunization and Health Coalitions starts next week The 11th National Conference on Immunization and Health Coalitions will be held in Seattle on May 21–23. This conference is a unique opportunity to network with colleagues and learn up-to-date immunization and coalition-building skills. Click on the links below for more information and don't forget to register immediately if you are interested in attending. After May 14, registration will only be available on site. Related Links Back to top IAC HANDOUTS Share IAC’s user-friendly immunization schedules with patients and parents IAC wants to remind readers that we have expanded our easy-to-use immunization schedules for patients to include all age groups. We have also developed a new suite of schedules that focuses on adults in risk groups for vaccination. Many are available in translation. Please review the selection below to see if any of these resources might be of help to you in your work setting.
Back to top FEATURED RESOURCES Binational immunization schedule for Mexico and the U.S. is updated The updated binational immunization resource tool addressing vaccination for children from birth through age 18 years provides an easy-to-read comparison of recommended vaccines in Mexico and the United States. This side-by-side presentation of recommended vaccines in Mexico and the U.S. helps healthcare providers identify vaccines needed by children living in the U.S. who received some vaccines in Mexico. Access the 2014 Binational Immunization Resource Tool for Children from Birth Through 18 Years Back to top IAC's sturdy laminated versions of the 2014 U.S. child/teen immunization schedule and the 2014 U.S. adult immunization schedule—order a supply for your healthcare setting today! IAC's laminated versions of the 2014 U.S. child/teen immunization schedule and the 2014 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. The child and adolescent schedule has eight pages (i.e., four double-sided pages) and is folded to measure 8.5" x 11". The adult immunization schedule has six pages (i.e., three double-sided pages) and is folded to measure 8.5" x 11".
  PRICING 1–4 copies: $7.50 each 5–19 copies: $5.50 each 20–99 copies: $4.50 each 100–499 copies: $4.00 each 500–999 copies: $3.50 each For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or emailadmininfo@immunize.org. You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page. Related Link Back to top JOURNAL ARTICLES AND NEWSLETTERS CDC publishes announcement about Hepatitis Awareness Month and National Hepatitis Testing Day CDC published Hepatitis Awareness Month and National Hepatitis Testing Day—May 2014 in the May 9 issue of MMWR (page 393). The first paragraph is reprinted below. In the United States, May is Hepatitis Awareness Month, and May 19 is National Hepatitis Testing Day. Although care and treatment can be life-saving, many of the estimated 800,000 to 1.4 million persons living with hepatitis B virus (HBV) infection and the estimated 3 million persons living with hepatitis C virus (HCV) infection are unaware of their infection and are not receiving necessary care and treatment. Guided by the goals of the 2014 U.S. Department of Health and Human Services Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis, CDC is working to expand access to HBV and HCV testing, care, and treatment. This issue of MMWR reports on the progress of these CDC activities in reaching the national prevention goals. Back to top CDC publishes article about early identification and care of people with chronic hepatitis B infection CDC published Early Identification and Linkage to Care of Persons with Chronic Hepatitis B Virus Infection—Three U.S. Sites, 2012–2014 in the May 9 issue of MMWR (pages 399–401). A summary made available to the press is reprinted below. Of the estimated 800,000 to 1.4 million persons living with chronic HBV in the U.S., as many as 70 percent were born in global regions with intermediate or higher HBV prevalence (≥2 percent). CDC recommends HBV testing for all persons born in these areas and linkage to medical care and preventive services for those who are infected. In 2012, CDC funded nine sites to implement HBV testing initiatives among foreign-born persons. This article summarizes the results from three sites (Minneapolis-St. Paul, MN; New York City, NY; and San Diego, CA) where 4,727 persons were tested, of whom 310 (6.5 percent) were positive. New York City and San Diego used community-based outreach to educate and test, while the Minnesota program tested newly arriving refugees at their first scheduled visit. Cultural and linguistic-specific approaches were necessary at all sites. A majority of those testing positive were informed of their results, counseled, and medically referred. Attendance at a follow-up visit was higher for those referred from the refugee program (91 percent) than from community-based sites (33 and 56 percent). Outreach and patient navigation activities require intensive effort but can effectively help to identify, counsel and refer infected persons. Strategies to improve linkage from community-based testing to medical care are needed. Back to top EDUCATION AND TRAINING May 15 webinar will discuss national strategies to combat viral hepatitis in the U.S. The White House Initiative on Asian Americans and Pacific Islanders and Hep B United will sponsor a one-hour webinar on May 15 at 3:00 p.m. (ET) on national strategies to address viral hepatitis. The webinar will feature speakers from the U.S. Department of Health and Human Services, the National Viral Hepatitis Roundtable, and the Association of Asian Pacific Community Health Organizations. Building on the success of the nation's first comprehensive cross-agency action plan, developed in 2011, the U.S. Departments of Health and Human Services, Housing and Urban Development, Justice, and Veterans Affairs released a three-year update of the plan in April 2014. The May 15 interactive webinar will discuss the plan, titled Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis. Access more information about this webinar, including registration information. Related Links Back to top  |
About IZ Express
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde